Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

SAN FRANCISCO--(BUSINESS WIRE)--After securing over $130M in funding and achieving multiple regulatory successes, Unlearn today announced changes to its executive leadership to support the commercial ...

SAN FRANCISCO--(BUSINESS WIRE)--In 2024, Unlearn ® achieved key milestones in advancing AI to eliminate trial and error in medicine. From securing $50M in Series C ...

Unlearn and Merck KGaA have announced a partnership to accelerate drug trials using medical digital twins of patients. Unlearn uses recent developments from deep learning to create digital twins of ...

A startup looking to develop digital copies of patients in clinical trials—allowing computer models of study participants to be generated ahead of time—has raised $50 million for its machine ...

Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...

Unlearn.AI has moved its headquarters into larger San Francisco offices in anticipation of employee growth. The locally based artificial intelligence startup relocated last month after it signed a ...